Delayed actual transaction price cuts slash expected savings
By Lee, Tak-Sun | translator Kim, Jung-Ju
24.02.22 12:10:53
가나다라
0
Despite completing the investigation last year, the government will not likely implement the system before the upcoming general election
Critics say that the inclusion of drugs in short supply and National Essential Drugs is a “strict measure”
The implementation of the actual transaction price system intended to reduce the drug price has been postponed. Since the system was initially scheduled to take effect in January, the price monitoring investigation reached conclusion. However, the price adjustments are being delayed for various reasons.
Pharmaceutical companies may benefit from the delay, but it results in financial loss for the National Health Insurance Service (NHIS) due to reduced effects of financial savings.
According to industry experts on the 22nd, the price cutting of the actual transaction prices of drugs has been repeatedly delayed. It is unlikely to be implemented in March as it has not been included
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)